58 related articles for article (PubMed ID: 16797458)
1. Feasibility of an SUV normalization to 1 hour after the 18F-FDG injection.
Laffon E; Vialard J; Allard M; Ducassou D
C R Biol; 2006 Jul; 329(7):520-6. PubMed ID: 16797458
[TBL] [Abstract][Full Text] [Related]
2. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
[TBL] [Abstract][Full Text] [Related]
3. Normoglycemic plasma glucose levels affect F-18 FDG uptake in the brain.
Claeys J; Mertens K; D'Asseler Y; Goethals I
Ann Nucl Med; 2010 Jul; 24(6):501-5. PubMed ID: 20237872
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional clinical PET in lung cancer: validation and practical strategies.
Calvo R; Martí-Climent JM; Richter JA; Peñuelas I; Crespo-Jara A; Villar LM; García-Velloso MJ
J Nucl Med; 2000 Mar; 41(3):439-48. PubMed ID: 10716316
[TBL] [Abstract][Full Text] [Related]
5. SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences.
Beaulieu S; Kinahan P; Tseng J; Dunnwald LK; Schubert EK; Pham P; Lewellen B; Mankoff DA
J Nucl Med; 2003 Jul; 44(7):1044-50. PubMed ID: 12843218
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.
Spence AM; Muzi M; Mankoff DA; O'Sullivan SF; Link JM; Lewellen TK; Lewellen B; Pham P; Minoshima S; Swanson K; Krohn KA
J Nucl Med; 2004 Oct; 45(10):1653-9. PubMed ID: 15471829
[TBL] [Abstract][Full Text] [Related]
7. Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues.
Paquet N; Albert A; Foidart J; Hustinx R
J Nucl Med; 2004 May; 45(5):784-8. PubMed ID: 15136627
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in a Tertiary Pediatric Hospital: A Prospective Study.
Lyons K; Seghers V; Sorensen JI; Zhang W; Paldino MJ; Krishnamurthy R; Rohren EM
AJR Am J Roentgenol; 2015 Nov; 205(5):1094-101. PubMed ID: 26496558
[TBL] [Abstract][Full Text] [Related]
9. Time course of tumor SUV in 18F-FDG PET of breast cancer: presentation of a simple model using a single reference point for time corrections of tumor SUVs.
Stahl AR; Heusner TA; Hartung V; Nagarajah J; Bockisch A; Hahn S; Antoch G; Jentzen W
J Nucl Med; 2011 Jan; 52(1):18-23. PubMed ID: 21149481
[TBL] [Abstract][Full Text] [Related]
10. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
[TBL] [Abstract][Full Text] [Related]
11. Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF.
Doot RK; Dunnwald LK; Schubert EK; Muzi M; Peterson LM; Kinahan PE; Kurland BF; Mankoff DA
J Nucl Med; 2007 Jun; 48(6):920-5. PubMed ID: 17504870
[TBL] [Abstract][Full Text] [Related]
12. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A
J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
[TBL] [Abstract][Full Text] [Related]
13. Comparison of SUV and Patlak slope for monitoring of cancer therapy using serial PET scans.
Freedman NM; Sundaram SK; Kurdziel K; Carrasquillo JA; Whatley M; Carson JM; Sellers D; Libutti SK; Yang JC; Bacharach SL
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):46-53. PubMed ID: 12483409
[TBL] [Abstract][Full Text] [Related]
14. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes.
Zhuang H; Pourdehnad M; Lambright ES; Yamamoto AJ; Lanuti M; Li P; Mozley PD; Rossman MD; Albelda SM; Alavi A
J Nucl Med; 2001 Sep; 42(9):1412-7. PubMed ID: 11535734
[TBL] [Abstract][Full Text] [Related]
15. Relationship between 18F-FDG uptake and breast density in women with normal breast tissue.
Vranjesevic D; Schiepers C; Silverman DH; Quon A; Villalpando J; Dahlbom M; Phelps ME; Czernin J
J Nucl Med; 2003 Aug; 44(8):1238-42. PubMed ID: 12902413
[TBL] [Abstract][Full Text] [Related]
16. Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography.
Degirmenci B; Wilson D; Laymon CM; Becker C; Mason NS; Bencherif B; Agarwal A; Luketich J; Landreneau R; Avril N
Nucl Med Commun; 2008 Jul; 29(7):614-22. PubMed ID: 18528183
[TBL] [Abstract][Full Text] [Related]
17. Grading of brain glioma with 1-11C-acetate PET: comparison with 18F-FDG PET.
Tsuchida T; Takeuchi H; Okazawa H; Tsujikawa T; Fujibayashi Y
Nucl Med Biol; 2008 Feb; 35(2):171-6. PubMed ID: 18312826
[TBL] [Abstract][Full Text] [Related]
18. 18F alpha-methyl tyrosine PET studies in patients with brain tumors.
Inoue T; Shibasaki T; Oriuchi N; Aoyagi K; Tomiyoshi K; Amano S; Mikuni M; Ida I; Aoki J; Endo K
J Nucl Med; 1999 Mar; 40(3):399-405. PubMed ID: 10086702
[TBL] [Abstract][Full Text] [Related]
19. Correlation of Glut-1 glucose transporter expression with.
Higashi K; Ueda Y; Sakurai A; Wang XM; Xu L; Murakami M; Seki H; Oguchi M; Taki S; Nambu Y; Tonami H; Katsuda S; Yamamoto I
Eur J Nucl Med; 2000 Dec; 27(12):1778-85. PubMed ID: 11189940
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis.
Nishiyama Y; Yamamoto Y; Fukunaga K; Takinami H; Iwado Y; Satoh K; Ohkawa M
J Nucl Med; 2006 Oct; 47(10):1571-6. PubMed ID: 17015889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
